Hematopoietic stem cell transplantation activity in Europe

Current Opinion in Hematology

Volumn 20, Issue 6, 2013, Pages 485-493

  Gratwohl, Alois ^a   Baldomero, Helen ^a   Passweg, Jakob ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Activity; Europe; hematopietic stem cell transplantation; macroeconomic aspects; trends

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADMINISTRATIVE PERSONNEL; APLASTIC ANEMIA; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; DECISION MAKING; DONOR; ECONOMIC ASPECT; EUROPE; HEALTH CARE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INBORN ERROR OF METABOLISM; INCOME; MEDICAL INFORMATION; MYELODYSPLASTIC SYNDROME; PHYSICIAN; PRIORITY JOURNAL; REGISTER; REVIEW; TECHNOLOGY; THALASSEMIA; VOLUNTEER;

EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84885396982     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328364f573     Document Type: Review

References (42)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354:1813-1826.
2. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357:1472-1475.
3. Passweg JR, Baldomero H, Bregni M, et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013. [Epub ahead of print]
4. Gratwohl A, Baldomero H, Aljurf M, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303:1617-1624.
5. http://www.wbmt.org/fileadmin/pdf/01-General/One-Million-Transplants- Fact-Sheet-FINAL.pdf. 2013. [Accessed 23 June 2013]
6. Passweg JR, Baldomero H, Gratwohl A, et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47:906-923.
7. Eckrich M, Pasquini M. Hematopoietic cell transplantation in Latin America. Hematology 2012; 1 (17 Suppl):S189-S191.
8. Bazarbachi A, Labopin M, Ghavamzadeh A, et al. Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers. Bone Marrow Transplant 2013; 48:1065-1069.
9. Urbano-Ispizua A, Baldomero H, Gratwohl A. Hematopoietic stem cell trans plantation in Europe. Differences between Eastern and Western countries. Hematology 2012; 17 (Suppl 1):S192-S194.
10. Lv M, Huang XJ. Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go. J Hematol Oncol 2012; 5:10.
11. Gratwohl A, Baldomero H, Gratwohl M, et al. Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study. Haematologica 2013; 98: 1282-1290.
12. Cornelissen JJ, Gratwohl A, Schlenk RF, et al. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol 2012; 9:579-590.
13. Palumbo A, Cavallo F. Have drug combinations supplanted stem cell trans-plantation in myeloma? Blood 2012; 120:4692-4698.
14. Gratwohl A. Bone marrow transplantation activity in Europe 1990. European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8:197-201.
15. Filosto M, Scarpelli M, Tonin P, et al. Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J Neurol 2012; 259:2699-2706.
16. Halter J, Schüpbach WM, Casali C, et al. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2011; 46:330-337.
17. Giugliani R. Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America. J Inherit Metab Dis 2012; 35:871-877.
18. Cavazzana-Calvo M, André-Schmutz I, Fischer A. Haematopoietic stem cell transplantation for SCID patients: where do we stand? Br J Haematol 2013; 160:146-152.
19. Vose JM. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management. Am J Hematol 2012; 87:604-609.
20. Gertz MA. Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012; 87:503-510.
21. Fernández de Larrea C, Kyle RA, Durie BG, et al. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 2013; 27:780-791.
22. Schönland SO, Dreger P, de Witte T, Hegenbart U. Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis. Bone Marrow Transplant 2012; 47:895-905.
23. Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol 2012; 87:804-814.
24. Koehne G, Giralt S. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care. Curr Opin Oncol 2012; 24:720-726.
25. Tyndall A. Successes and failures of stem cell transplantation in autoimmune diseases. HematologyAmSoc Hematol Educ Program 2011; 2011:280-284.
26. Hawkey CJ. Stem cells as treatment in inflammatory bowel disease. Dig Dis 2012; 2013; 30 (Suppl 3):134-139.
27. Pasquini MC, Voltarelli J, Atkins HL, et al. Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2012; 18:1471-1478.
28. Snowden JA, Pearce RM, Lee J, et al. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009. Br J Haematol 2012; 157:742-746.
29. Mancardi GL, Sormani MP, Di Gioia M, et al. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multicentre experience. Mult Scler 2012; 18:835-842.
30. Martin I, Baldomero H, Bocelli-Tyndall C, et al. The survey on cellular and engineered tissue therapies in Europe in 2010. Tissue Eng Part A 2012; 18:2268-2279.
31. Ricart E. Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD. Dig Dis 2012; 30:387-391.
32. Ribeiro Dos Santos R, Rassi S, Feitosa G, et al. Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial. Circulation 2012; 125:2454-2461.
33. Rasheed W, Ghavamzadeh A, Hamladji R, et al. Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey. Hematol Oncol Stem Cell Ther 2013; 6:14-19.
34. Ruutu T, van Biezen A, Hertenstein B, et al. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012; 47:1459-1464.
35. Gratwohl A, Passweg J, Baldomero H, et al. Economics, healthcare systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol 2002; 117:451-468.
36. Passweg JR, Baldomero H, Bargetzi M, et al. Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss Med Wkly 2013; 143:w13757.
37. Blommestein HM, Verelst SG, Huijgens PC, et al. Real-world costs of autologous and allogeneic stem cell transplantations for haemato-logical diseases: a multicentre study. Ann Hematol 2012; 91:1945-1952.
38. Gratwohl A, Schwendener A, Baldomero H, et al. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology. Haematologica 2010; 95:637-643.
39. Barr RD. Economic evaluation of hematopoietic stem cell transplantation. Hematology 2012; 17 (Suppl 1):S198-201.
40. Svahn BM, Remberger M, Alvin O, et al. Increased costs after allogeneic haematopoietic SCT are associated with major complications and retransplantation. Bone Marrow Transplant 2012; 47:706-715.
41. World Health Organization. WHO guiding principles on human cell, tissue and organ transplantation. Transplantation 2010; 90:229-233.
42. Gratwohl A, Brand R, Niederwieser D, et al. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. J Clin Oncol 2011; 29:1980-1986.